Furthermore, knockdown of EZH2 to investigate whether histone methylation modification contributes to the decrease in SPRY4-IT1 expression showed that SPRY4-IT1 expression was instead promoted in NSCLC cells (Figures 2a and b and Supplementary Figure S2c). This evidence concerns the gene EZH2 and non-small cell lung carcinoma.